State of research in the field of the creation of plant vaccines for veterinary use

Russian Journal of Plant Physiology

Volumn 62, Issue 1, 2015, Pages 23-38

  Permyakova, N V ^a   Uvarova, E A ^a   Deineko, E V ^a  

^a INSTITUTE OF CYTOLOGY AND GENETICS   (Russian Federation)

Author keywords

Biosafety; Expression systems; Plant vaccines; Recombinant proteins; Transgenic plants; Veterinary

Indexed keywords

EID: 84929330114     PISSN: 10214437     EISSN: None     Source Type: Journal    
DOI: 10.1134/S1021443715010100     Document Type: Review

References (92)

1. Rybicki, E. P., Plant-produced vaccines: promise and reality, Drug Discov. Today, 2009, vol. 14, pp. 16-24.
2. Thomas, D. R., Penney, C. A., Majumder, A., and Walmsley, A. M., Evolution of plant-made pharmaceu-ticals, Int. J. Mol. Sci., 2011, vol. 12, pp. 3220-3236.
3. Meeusen, E. N. T., Walker, J., Peters, A., Pastoret, P.-P., and Jungersen, G., Current status of veterinary vac-cines, Clin. Microbiol. Rev., 2007, vol. 20, pp. 489-510.
4. Hefferon, K., Clinical trials fuel the promise of plant-derived vaccines, Am. J. Chin. Med., 2010, vol. 7, pp. 30-37.
5. Mason, H. S., Lam, M.-K. D., and Arntzen, C. J., Expression of hepatitis B surface antigen in transgenic plants, Proc. Natl. Acad. Sci. USA, 1992, vol. 89, pp. 11745-11749.
6. Haq, T., Mason, H. S., Clements, J. D., and Arntzen, C. J., Oral immunization with a recombinant bacterial anti-gen produced in transgenic plants, Science, 1995, vol. 268, pp. 714-716.
7. Mason, H. S., Haq, T. A., Clements, J. D., and Arn-tzen, C. J., Edible vaccine protects mice against Escher-ichia coli heat-labile enterotoxin (LT): potatoes express-ing a synthetic LT-B gene, Vaccine, 1998, vol. 16, pp. 1336-1343.
8. Arakawa, T., Chong, D. K. X., and Langridge, W., Effi-cacy of food plant-based oral cholera toxin B subunit vaccine, Nat. Biotechnol., 1998, vol. 16, pp. 292-297.
9. Tacket, C. O., Mason, H. S., Losonsky, G., Clements, J. D., Levine, M. M., and Arntzen, C. J., Immunogenicity in humans of a recombinant bacte-rial antigen delivered in a transgenic potato, Nat. Med., 1998, vol. 4, pp. 607-609.
10. Limaye, A., Koya, V., Samsam, M., and Daniell, H., Receptor-mediated oral delivery of a bioencapsulated green fluorescent protein expressed in transgenic chlo-roplasts into the mouse circulatory system, FASEB J., 2006, vol. 20, pp. 959-961.
11. Pelosi, A., Shepherd, R., and Walmsley, A. M., Delivery of plant-made vaccines and therapeutics, Biotechnol. Adv., 2012, vol. 30, pp. 440-448.
12. Lawson, L. B., Norton, E. B., and Clements, J. D., Defending the mucosa: adjuvant and carrier formula-tions for mucosal immunity, Curr. Opin. Immunol., 2011, vol. 23, pp. 414-420.
13. Brandtzaeg, P., Induction of secretory immunity and memory at mucosal surfaces, Vaccine, 2007, vol. 25, pp. 5467-5484.
14. Kwon, K. C., Verma, D., Singh, N. D., Herzog, R., and Daniell, H., Oral delivery of human biopharmaceuti-cals, autoantigens and vaccine antigens bioencapsu-lated in plant cells, Adv. Drug Deliv. Rev., 2012, vol. 65, pp. 782-799.
15. Hefferon, K. L., The mucosal immune response to plant-derived vaccines, Pharm. Res., 2010, vol. 27, pp. 2040-2042.
16. Gomord, V. and Faye, L., Posttranslational modifica-tion of therapeutic proteins in plants, Curr. Opin. Plant Biol., 2004, vol. 7, pp. 171-181.
17. Boothe, J., Nykiforuk, C., Shen, Y., Zaplachinski, S., Szarka, S., Kuhlman, P., Murray, E., Morck, D., and Moloney, M. M., Seed-based expression systems for plant molecular farming, Plant Biotechnol. J., 2010, vol. 8, pp. 588-606.
18. Kaufman, J. and Kalaitzandonakes, N., The economic potential of plant-made pharmaceuticals in the manu-facture of biologic pharmaceuticals, J. Commerc. Bio-technol., 2011, vol. 17, pp. 173-182.
19. Nochi, T., Takagi, H., Yuki, Y., Yang, L., Masumura, T., Mejima, M., Nakanishi, U., Matsumura, A., Uozumi, A., Hiroi, T., Morita, S., Tanaka, K., Takaiwa, F., and Kiyono, H., Rice-based mucosal vac-cine as a global strategy for cold-chain-and needle-free vaccination, Proc. Natl. Acad. Sci. USA, 2007, vol. 104, pp. 10 986-10 991.
20. Tokuhara, D., Yuki, Y., Nochi, T., Kodama, T., Mejima, M., Kurokawa, S., Takahashi, Y., Nanno, M., Nakanishi, U., Takaiwa, F., Honda, T., and Kiyono, H., Secretory IgA-mediated protection against V. cholerae and heat-labile enterotoxin-producing enterotoxigenic Escherichia coli by rice-based vaccine, Proc. Natl. Acad. Sci. USA, 2010, vol. 107, pp. 8794-8799.
21. Oakes, J. L., Bost, K. L., and Piller, K. J., Stability of a soybean seed-derived vaccine antigen following long-term storage, processing and transport in the absence of a cold chain, J. Sci. Food Agric., 2009, vol. 89, pp. 2191-2199.
22. Zhang, X., Buehner, N. A., Hutson, A. M., Estes, M. K., and Mason, H. S., Tomato is a highly effective vehicle for expression and oral immunization with Norwalk virus capsid protein, Plant Biotechnol. J., 2006, vol. 4, pp. 419-432.
23. Nagels, B., Weterings, K., Callewaert, N., and van Damme, E. J. M., Production of plant made pharma-ceuticals: from plant host to functional protein, CRC Crit. Rev. Plant Sci., 2012, vol. 31, pp. 148-180.
24. Walsh, G. and Jefferis, R., Post-translational modifica-tions in the context of therapeutic proteins, Nat. Bio-technol., 2006, vol. 24, pp. 1241-1252.
25. Decker, E. L. and Reski, R., Current achievements in the production of complex biopharmaceuticals with moss bioreactors, Bioprocess Biosyst. Eng., 2008, vol. 31, pp. 3-9.
26. Pniewski, T., Kapusta, J., Boci g, P., Wojciechowicz, J., Kostrzak, A., Gdula, M., Fedorowicz-Stro ska, O., Wójcik, P., Otta, H., Samardakiewicz, S., Wolko, B., and P ucienniczak, A., Low-dose oral immunization with lyophilized tissue of herbicide-resistant lettuce expressing hepatitis B surface antigen for prototype plant-derived vaccine tablet formulation, J. Appl. Genet., 2011, vol. 52, pp. 125-136.
27. Matzke, M., Kanno, T., Daxinger, L., Huettel, B., and Matzke, A. J. M., RNA-mediated chromatin-based silencing in plants, Curr. Opin. Cell Biol., 2009, vol. 21, pp. 367-376.
28. Marenkova, T. V. and Deineko, E. V., Transcriptional gene silencing in plants, Russ. J. Genet., 2010, vol. 46, pp. 581-592.
29. Fischer, R., Stoger, E., Schillberg, S., Christou, P., and Twyman, R. M., Plant-based production of biopharma-ceuticals, Curr. Opin. Plant Biol., 2004, vol. 7, pp. 152-158.
30. Desai, P. N., Shrivastava, N., and Padh, H., Production of heterologous proteins in plants: strategies for optimal expression, Biotechnol. Adv., 2010, vol. 28, pp. 427-435.
31. Vyacheslavova, A. O., Berdichevets, I. N., Tyurin, A. A., Shimshilashvili, Kh. R., Mustafaev, O. N., and Golden-kova-Pavlova, I. V., Expression of heterologous genes in plant systems: new possibilities, Russ. J. Genet., 2012, vol. 48, pp. 1067-1079.
32. Oey, M., Lohse, M., Kreikemeyer, B., and Bock, R., Exhaustion of the chloroplast protein synthesis capac-ity by massive expression of a highly stable protein anti-biotic, Plant J., 2009, vol. 57, pp. 436-445.
33. Bally, J., Job, C., Belghazi, M., and Job, D., Metabolic adaptation in transplastomic plants massively accumu-lating recombinant proteins, PLoS One, 2011, vol. 6: e25289.
34. Shchelkunov, S. N., Konstantinov, Yu. M., and Deineko, E. V., Transplastomic plants, Vavilov. Zhurn. Genet. Selekt., 2011, vol. 15, pp. 808-817.
35. De Cosa, B., Moar, W., Lee, S. B., Miller, M., and Daniell, H., Overexpression of the Bt cry2Aa2 operon in chloroplasts leads to formation of insecticidal crys-tals, Nat. Biotechnol., 2001, vol. 19, pp. 71-74.
36. Verma, D. and Daniell, H., Chloroplast vector systems for biotechnology applications, Plant Physiol., 2007, vol. 145, pp. 1129-1143.
37. Ruf, S., Karcher, D., and Bock, R., Determining the transgene containment level provided by chloroplast transformation, Proc. Natl. Acad. Sci. USA, 2007, vol. 104, pp. 6998-7002.
38. Daniell, H., Lee, S. B., Panchal, T., and Wiebe, P. O., Expression of the native cholera toxin B subunit gene and assembly as functional oligomers in transgenic tobacco chloroplasts, J. Mol. Biol., 2001, vol. 311, pp. 1001-1009.
39. Leelavathi, S. and Reddy, V. S., Chloroplast expression of His-tagged GUS-fusions: a general strategy to over-produce and purify foreign proteins using transplas-tomic plants as bioreactors, Mol. Breed., 2003, vol. 11, pp. 49-58.
40. Lee, S. B., Kwon, H. B., Kwon, S. J., Park, S. C., Jeong, M. J., Han, S. E., Byun, M. O., and Daniell, H., Accumulation of trehalose within transgenic chloro-plasts confers drought tolerance, Mol. Breed., 2003, vol. 11, pp. 1-13.
41. Tiwari, S., Verma, P. C., Singh, P. K., and Tuli, R., Plants as bioreactors for the production of vaccine anti-gens, Biotechnol. Adv., 2009, vol. 27, pp. 449-467.
42. Xu, J., Ge, X., and Dolan, M. C., Towards high-yield production of pharmaceutical proteins with plant cell suspension cultures, Biotechnol. Adv., 2011, vol. 29, pp. 278-299.
43. Matzke, A. J. and Matzke, M. A., Position effects and epigenetic silencing of plant transgenes, Curr. Opin. Plant Biol., 1998, vol. 1, pp. 142-148.
44. Huang, T. K. and McDonald, K. A., Bioreactor systems for in vitro production of foreign proteins using plant cell cultures, Biotechnol. Adv., 2012, vol. 30, pp. 398-409.
45. Vunsh, R., Li, J., Hanania, U., Edelman, M., Flaish-man, M., Perl, A., Wisniewski, J.-P., and Freyssinet, G., High expression of transgene protein in Spirodela, Plant Cell Rep., 2007, vol. 26, pp. 1511-1519.
46. Specht, E., Miyake-Stoner, S., and Mayfield, S., Micro-algae come of age as a platform for recombinant protein production, Biotechnol. Lett., 2010, vol. 32, pp. 1373-1383.
47. Sun, M., Qian, K., Su, N., Chang, H., Liu, J., Shen, G., and Chen, G., Foot-and-mouth disease virus VP1 pro-tein fused with cholera toxin B subunit expressed in Chlamydomonas reinhardtii chloroplast, Biotechnol. Lett., 2003, vol. 25, pp. 1087-1092.
48. Dreesen, I. A. J., Charpin-El, Hamri, G., and Fuss-enegger, M., Heat-stable oral alga-based vaccine pro-tects mice from Staphylococcus aureus infection, J. Bio-technol., 2010, vol. 145, pp. 273-280.
49. Surzycki, R., Greenham, K., Kitayama, K., Dibal, F., Wagner, R., Rochaix, J.-D., Ajam, T., and Surzycki, S., Factors effecting expression of vaccines in microalgae, Biologicals, 2009, vol. 37, pp. 133-138.
50. He, D. M., Qian, K. X., Shen, G. F., Zhang, Z. F., Li, Y. N., Su, Z. L., and Shao, H. B., Recombination and expression of classical swine fever virus (CSFV) structural protein E2 gene in Chlamydomonas rein-hardtii chroloplasts, Colloids Surf. B: Biointerfaces, 2007, vol. 55, pp. 26-30.
51. Gleba, Y., Klimyuk, V., and Marillonnet, S., Viral vec-tors for the expression of proteins in plants, Curr. Opin. Biotechnol., 2007, vol. 18, pp. 134-141.
52. Sheludko, Y. V., Agrobacterium-mediated transient expression as an approach to production of recombi-nant proteins in plants, Recent Pat. Biotechnol., 2008, vol. 2, pp. 198-208.
53. Roy, G., Weisburg, S., Rabindran, S., and Yusibov, V., A novel two-component tobacco mosaic virus-based vector system for high-level expression of multiple ther-apeutic proteins including a human monoclonal anti-body in plants, Virology, 2010, vol. 405, pp. 93-99.
54. Gleba, Y., Klimyuk, V., and Marillonnet, S., Magnifec-tion-a new platform for expressing recombinant vac-cines in plants, Vaccine, 2005, vol. 23, pp. 2042-2048.
55. Streatfield, S. J., Jilka, J. M., Hood, E. E., Turner, D. D., Bailey, M. R., Mayor, J. M., Woodard, S. L., Beifuss, K. K., Horn, M. E., Delaney, D. E., Tizard, I. R., and Howard, J. A., Plant-based vaccines: unique advan-tages, Vaccine, 2001, vol. 19, pp. 2742-2748.
56. Guerrero-Andrade, O., Loza-Rubio, E., Olivera-Flores, T., Fehérvári-Bone, T., and Gómez-Lim, M. A., Expression of the Newcastle disease virus fusion protein in transgenic maize and immunological studies, Trans-genic Res., 2006, vol. 15, pp. 455-463.
57. Gil, F., Reytor, E., Pérez-Filgueira, D. M., and Escrib-ano, J. M., Multimerization of peptide antigens for pro-duction of stable immunogens in transgenic plants, J. Biotechnol., 2007, vol. 128, pp. 512-518.
58. Wang, Y., Deng, H., Zhang, X., Xiao, H., Jiang, Y., Song, Y., Fang, L., Xiao, S., Zhen, Y., and Chen, H., Generation and immunogenicity of Japanese encepha-litis virus envelope protein expressed in transgenic rice, Biochem. Biophys. Res. Commun., 2009, vol. 380, pp. 292-297.
59. Yang, C. D., Liao, J. T., Lai, C. Y., Jong, M. H., Liang, C. M., Lin, Y. L., Lin, N. S., Hsu, Y. H., and Liang, S. M., Induction of protective immunity in swine by recombinant bamboo mosaic virus express-ing foot-and-mouth disease virus epitopes, BMC Bio-technol, 2007, vol. 7, p. 62.
60. Marconi, G., Albertini, E., Barone, P., de Marchis, F., Lico, C., Marusic, C., Rutili, D., Veronesi, F., and Porceddu, A., In planta production of two peptides of the classical swine fever virus (CSFV) E2 glycoprotein fused to the coat protein of potato virus X, BMC Bio-technol., 2006, vol. 6, p. 29.
61. Yusibov, V., Hooper, D. C., Spitsin, S. V., Fleysh, N., Kean, R. B., Mikheeva, T., Deka, D., Karasev, A., Cox, S., Randall, J., and Koprowski, H., Expression in plants and immunogenicity of plant virus-based exper-imental rabies vaccine, Vaccine, 2002, vol. 20, pp. 3155-3164.
62. Lamphear, B. J., Streatfield, S. J., Jilka, J. M., Brooks, C. A., Barker, D. K., Turner, D. D., Delaney, D. E., Garcia, M., Wiggins, B., Woodard, S. L., Hood, E. E., Tizard, I. R., Lawhorn, B., and Howard, J. A., Delivery of subunit vaccines in maize seed, J. Control Release, 2002, vol. 85, pp. 169-180.
63. Lamphear, B. J., Jilka, J. M., Kesl, L., Welter, M., Howard, J. A., and Streatfield, S. J., A corn-based deliv-ery system for animal vaccines: an oral transmissible gastroenteritis virus vaccine boosts lactogenic immu-nity in swine, Vaccine, 2004, vol. 22, pp. 2420-2424.
64. Tuboly, T., Yu, W., Bailey, A., Degrandis, S., Du, S., Erickson, L., and Nagy, E., Immunogenicity of porcine transmissible gastroenteritis virus spike protein expressed in plants, Vaccine, 2000, vol. 18, pp. 2023-2028.
65. Martín-Alonso, J. M., Castañón, S., Alonso, P., Parra, F., and Ordás, R., Oral immunization using tuber extracts from transgenic potato plants expressing rabbit hemorrhagic disease virus capsid protein, Transgenic Res., 2003, vol. 12, pp. 127-130.
66. Mikschofsky, H., Schirrmeier, H., Keil, G. M., Lange, B., Polowick, P. L., Keller, W., and Broer, I., Pea-derived vaccines demonstrate high immunoge-nicity and protection in rabbits against rabbit haemor-rhagic disease virus, Plant Biotechnol. J., 2009, vol. 7, pp. 537-549.
67. Paul, M. and Ma, J. K. C., Plant-made pharmaceuti-cals: leading products and production platforms, Bio-technol. Appl. Biochem., 2011, vol. 58, pp. 58-67.
68. Matsumura, T., Itchoda, N., and Tsunemitsu, H., Pro-duction of immunogenic VP6 protein of bovine group A rotavirus in transgenic potato plants, Arch. Virol., 2002, vol. 147, pp. 1263-1270.
69. O'Brien, G. J., Bryant, C. J., Voogd, C., Greenberg, H. B., Gardner, R. C., and Bellamy, A. R., Rotavirus VP6 expressed by PVX vectors in Nicotiana benthamiana coats PVX rods and also assembles into viruslike parti-cles, Virology, 2000, vol. 270, pp. 444-453.
70. Yu, J. and Langridge, W., Expression of rotavirus capsid protein VP6 in transgenic potato and its oral immuno-genicity in mice, Transgenic Res., 2003, vol. 12, pp. 163-169.
71. Wigdorovitz, A., Mozgovoj, M., Dus Santos, M. J., Parreño, V., Gómez, C., Pérez-Filgueira, D. M., Trono, K. G., Ríos, R. D., Franzone, P. M., Fernán-dez, F., Carrillo, C., Babiuk, L. A., Escribano, J. M., and Borca, M. V., Protective lactogenic immunity conferred by an edible peptide vaccine to bovine rotavirus produced in transgenic plants, J. Gen. Virol., 2004, vol. 85, pp. 1825-1832.
72. Pérez Filgueira, D. M., Zamorano, P. I., Dominguez, M. G., Taboga, O., del Médico, Zajac, M. P., Puntel, M., Romera, S. A., Morris, T. J., Borca, M. V., and Sadir, A. M., Bovine herpes virus gD protein pro-duced in plants using a recombinant tobacco mosaic virus (TMV) vector possesses authentic antigenicity, Vaccine, 2003, vol. 21, pp. 4201-4209.
73. Wigdorovitz, A., Carrillo, C., Dus Santos, M. J., Trono, K., Peralta, A., Gómez, M. C., Ríos, R. D., Franzone, P. M., Sadir, A. M., Escribano, J. M., and Borca, M. V., Induction of a protective antibody response to foot and mouth disease virus in mice fol-lowing oral or parenteral immunization with alfalfa transgenic plants expressing the viral structural protein VP1, Virology, 1999, vol. 255, pp. 347-353.
74. Wang, D. M., Zhu, J. B., Peng, M., and Zhou, P., Induction of a protective antibody response to FMDV in mice following oral immunization with transgenic Stylosanthes spp. as a feedstuff additive, Transgenic Res., 2008, vol. 17, pp. 1163-1170.
75. Khandelwal, A., Lakshmi, Sita, G., and Shaila, M. S., Expression of hemagglutinin protein of rinderpest virus in transgenic tobacco and immunogenicity of plant-derived protein in a mouse model, Virology, 2003, vol. 308, pp. 207-215.
76. Khandelwal, A., Renukaradhya, G. J., Rajasekhar, M., Lakshmi, Sita, G., and Shaila, M. S., Systemic and oral immunogenicity of hemagglutinin protein of rinderpest virus expressed by transgenic peanut plants in a mouse model, Virology, 2004, vol. 323, pp. 284-291.
77. Satyavathi, V. V., Prasad, V., Khandelwal, A., Shaila, M. S., and Lakshmi, Sita, G., Expression of hemagglutinin protein of rinderpest virus in trans-genic pigeon pea [Cajanus cajan (L.) Millsp.] plants, Plant Cell Rep., 2003, vol. 21, pp. 651-658.
78. Gómez, N., Wigdorovitz, A., Castañón, S., Gil, F., Ordás, R., Borca, M. V., and Escribano, J. M., Oral immunogenicity of the plant derived spike protein from swine-transmissible gastroenteritis coronavirus, Arch. Virol., 2000, vol. 145, pp. 1725-1732. 79.
79. Kang, T. J., Seo, J. E., Kim, D. H., Kim, T. G., Jang, Y. S., and Yang, M. S., Cloning and sequence analysis of the Korean strain of spike gene of porcine epidemic diarrhea virus and expression of its neutraliz-ing epitope in plants, Protein Expr. Purif., 2005, vol. 41, pp. 378-383.
80. Gil, F., Titarenko, E., Terrada, E., Arcalís, E., and Escribano, J. M., Successful oral prime-immunization with VP60 from rabbit haemorrhagic disease virus pro-duced in transgenic plants using different fusion strate-gies, Plant Biotechnol. J., 2006, vol. 4, pp. 135-143.
81. Berinstein, A., Vazquez-Rovere, C., Asurmendi, S., Gómez, E., Zanetti, F., Zabal, O., Tozzini, A., Conte, Grand, D., Taboga, O., Calamante, G., Bar-rios, H., Hopp, E., and Carrillo, E., Mucosal and sys-temic immunization elicited by Newcastle disease virus (NDV) transgenic plants as antigens, Vaccine, 2005, vol. 23, pp. 5583-5589.
82. Yang, Z., Liu, Q., Pan, Z., Yu, H., and Jiao, X., Expres-sion of the fusion glycoprotein of Newcastle disease virus in transgenic rice and its immunogenicity in mice, Vaccine, 2007, vol. 25, pp. 591-598.
83. Zhou, J., Wu, J., Cheng, L., Zheng, X., Gong, H., Shang, S., and Zhou, E., Expression of immunogenic S1 glycoprotein of infectious bronchitis virus in trans-genic potatoes, J. Virol., 2003, vol. 77, pp. 9090-9093.
84. Nemchinov, L. G. and Natilla, A., Transient expression of the ectodomain of matrix protein 2 (M2e) of avian influenza A virus in plants, Protein Expr. Purif., 2007, vol. 56, pp. 153-159.
85. Kalthoff, D., Giritch, A., Geisler, K., Bettmann, U., Klimyuk, V., Hehnen, H.-R., Gleba, Y., and Beer, M., Immunization with plant-expressed hemagglutinin protects chickens from lethal highly pathogenic avian influenza virus H5N1 challenge infection, J. Virol., 2010, vol. 84, pp. 12 002-12 010.
86. Hu, J., Ni, Y., Dryman, B. A., Meng, X. J., and Zhang, C., Immunogenicity study of plant-made oral subunit vaccine against porcine reproductive and res-piratory syndrome virus (PRRSV), Vaccine, 2012, vol. 30, pp. 2068-2074.
87. McGarvey, P. B., Hammond, J., Deinelt, M. M., Hooper, D. C., Fu, Z. F., Dietzschold, B., Koprowski, H., and Michaels, F. H., Expression of the rabies virus glycoprotein in transgenic tomatoes, Nat. Biotechnol., 1995, vol. 13, pp. 1484-1487.
88. Modelska, A., Dietzschold, B., Sleysh, N., Fu, Z. F., Steplewski, K., Hooper, D. C., Koprowski, H., and Yusibov, V., Immunization against rabies with plant-derived antigen, Proc. Natl. Acad. Sci. USA, 1998, vol. 95, pp. 2481-2485.
89. Loza-Rubio, E., Rojas-Anaya, E., Gomez-Lim, M., and Olivera, M. T. J., Development of an edible rabies vaccine in maize using the Vnukovo strain, Dev. Biol. (Basel), 2008, vol. 131, pp. 477-482.
90. Loza-Rubio, E., Rojas-Anaya, E., López, J., Olivera-Flores, M. T., Gómez-Lim, M., and Tapia-Pérez, G., Induction of a protective immune response to rabies virus in sheep after oral immunization with transgenic maize, expressing the rabies virus glycoprotein, Vac-cine, 2012, vol. 30, pp. 5551-5556.
91. Perea-Arango, I., Loza-Rubio, E., Rojas-Anaya, E., Olivera-Flores, T., Gonzalez de la Vara, L., and Gómez-Lim, M. A., Expression of the rabies virus nucleoprotein in plants at high-levels and evaluation of immune responses in mice, Plant Cell Rep., 2008, vol. 27, pp. 677-685.
92. Rojas-Anaya, E., Loza-Rubio, E., Olivera-Flores, M. T., and Gomez-Lim, M., Expression of rabies virus G pro-tein in carrots (Daucus carota), Transgenic Res., 2009, vol. 18, pp. 911-919.